Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Clinical practice guideline for endoscopic resection of early gastrointestinal cancer
찬혁박， 동훈양， 정욱김， 지현김… - The Korean Journal …, 2020 - synapse.koreamed.org
Although surgery was the standard treatment for early gastrointestinal cancers, endoscopic
resection is now a standard treatment for early gastrointestinal cancers without regional …
resection is now a standard treatment for early gastrointestinal cancers without regional …
Clinical and translational advances in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is among the most deadly forms of human
malignancy characterized by late stage diagnosis, metastasis, therapy resistance and …
malignancy characterized by late stage diagnosis, metastasis, therapy resistance and …
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
Background Trifluridine/tipiracil showed activity and was well tolerated in a phase 2 study of
pretreated patients with advanced gastric cancer done in Japan. We investigated whether …
pretreated patients with advanced gastric cancer done in Japan. We investigated whether …
Esophageal cancer
MW Short, KG Burgers, VT Fry - American family physician, 2017 - aafp.org
Esophageal cancer has a poor prognosis and high mortality rate, with an estimated 16,910
new cases and 15,910 deaths projected in 2016 in the United States. Squamous cell …
new cases and 15,910 deaths projected in 2016 in the United States. Squamous cell …
Safety, activity, and biomarkers of SHR-1210, an anti-PD-1 antibody, for patients with advanced esophageal carcinoma
J Huang, B Xu, H Mo, W Zhang, X Chen… - Clinical Cancer …, 2018 - aacrjournals.org
Purpose: The current management of advanced esophageal squamous cell carcinoma
(ESCC) remains unsatisfactory. We investigated the safety, efficacy, and biomarkers of SHR …
(ESCC) remains unsatisfactory. We investigated the safety, efficacy, and biomarkers of SHR …
Recent advances in treating oesophageal cancer
K Harada, JE Rogers, M Iwatsuki… - …, 2020 - pmc.ncbi.nlm.nih.gov
Esophageal cancer (EC) is an aggressive malignancy with an increasing incidence and a
poor prognosis. EC is histologically divided into two major categories: adenocarcinoma …
poor prognosis. EC is histologically divided into two major categories: adenocarcinoma …
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
Background Fusobacterium nucleatum (F. nucleatum) is a gut microbe implicated in
gastrointestinal tumorigenesis. Predicting the chemotherapeutic response is critical to …
gastrointestinal tumorigenesis. Predicting the chemotherapeutic response is critical to …
[HTML][HTML] Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: a diagnostic systematic review and …
DJJM de Gouw, BR Klarenbeek, M Driessen… - Journal of Thoracic …, 2019 - Elsevier
Introduction Up to 32% of patients with esophageal cancer show a pathological complete
response (ypCR) after neoadjuvant therapy. To prevent overtreatment, the indication to …
response (ypCR) after neoadjuvant therapy. To prevent overtreatment, the indication to …
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a …
G Zhang, J Yuan, C Pan, Q Xu, X Cui, J Zhang, M Liu… - …, 2023 - thelancet.com
Background Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant
therapy have been applied to the treatment of esophageal squamous cell carcinoma …
therapy have been applied to the treatment of esophageal squamous cell carcinoma …
Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma
Y Tachimori, S Ozawa, H Numasaki, H Matsubara… - Esophagus, 2016 - Springer
Background The extent of node dissection in esophageal cancer surgery is usually
estimated by the number of resected nodes, irrespective of the area of dissection. The …
estimated by the number of resected nodes, irrespective of the area of dissection. The …